Enterome to move its research laboratories

Establishing labs in France's biocluster Genopole

21-Sep-2017 - Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology and research in genomics and genetics. The new laboratories brings Enterome closer to its ...

Enterome and Nestlé Health Science launch new diagnostics company

11-Jul-2017 - ENTEROME SA and Nestlé Health Science, announce the joint creation of Microbiome Diagnostics Partners (MDP). This company will bring together complementary, world-leading platforms and capabilities enabling the discovery and development of innovative diagnostics through to commercialization in ...

Takeda and Enterome enter strategic drug discovery collaboration

Focus on microbiome targets across multiple gastrointestinal disorders

12-Jan-2016 - Takeda Pharmaceutical Company Ltd. and Enterome Bioscience SA announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including ...

Synthetic Biologics and Enterome Bioscience Collaborate on C. difficile Microbiome Research Program

Study to Define Impact of Beta-Lactam Antibiotics on Intestinal Bacteria

11-Jun-2014 - Synthetic Biologics, Inc. and Enterome Bioscience SA announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients. As part of this collaboration, a clinical microbiome ...

Enterome raises EUR five million in series A funding round

28-Mar-2012 - Enterome, a stratified medicine company developing biomarkers for chronic and challenging medical conditions relating to abnormalities of bacterial composition of the human intestine (metabolic and bowel diseases), announces a first closing of a series A funding round, raising EUR five million. ...